Summary
Recent studies suggest that serotonin reuptake inhibitors are helpful in at least some symptoms of autism. Inositol is a precursor of the second messenger for some serotonin receptors, and has been reported effective in depression, panic disorder and obsessive-compulsive disorder. However a controlled double-blind crossover trial of inositol 200 mg/kg per day showed no benefit in 9 children with autism. Since biochemical studies suggest that inositol may augment serotonin effects, future studies could evaluate inositol in children already receiving serotonin reuptake inhibitors.
This is a preview of subscription content, log in via an institution to check access.
References
Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH (1995) Double blind controlled trial of inositol treatment of panic disorder. Am J Psychiatry 152: 1084–1086
Conners CK (1969) A teacher rating scale for use in drug studies with children. Am J Psychiatry 126: 884–888
Cook EH, Rowlett R, Jaselskis C, et al (1992) Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 311: 739–745
Fux M, Levine J, Aviv A, Belmaker RH (1996) Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 153: 1219–21
Garber HJ, McGonigle JJ, Slomka GT, Monteverde E (1992) Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. J Am Acad Child Adolesc Psychiatry 31: 1157–4460
Gordon CT, State RC, Nelson JE, Hamburger SD, Rapaport JL (1993) A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50: 441–447
Hallman M, Bry K, Hoppu K, Lappi M, Pohjavouri M (1992) Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 326: 1233–1239
Levine J, Barak Y, Gonsalves M, Szor H, Elizur A, Kofman O, Belmaker RH (1995) A double-blind controlled trial of inositol treatment of depression. Am J Psychiatry 152: 792–794
Rahman S, Neuman RS (1993) Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization. Brain Res 631: 349–351
Schopler E, Reichler RJ, Devellis RF, et al (1980) Toward objective classification of childhood autism: childhood autism rating scale. J Autism Dev Disord 10: 91–103
Vocci FJ, Deutsch SI (1990) Novel drug development in developmental disorders. In: Deutsch SI, Weizman A, Weizman R (eds) Application of basic neuroscience to child psychiatry. Plenum Publishing Corporation, New York
Zeisel SH (1986) Dietary influences on neurotransmission. Adv Pediatr 33: 23–47
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levine, J., Aviram, A., Holan, A. et al. Inositol treatment of autism. J. Neural Transmission 104, 307–310 (1997). https://doi.org/10.1007/BF01273191
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01273191